Hematopoietic Stem CellsBone Marrow TransplantationStem CellsBone Marrow CellsBone MarrowTransplantation, HomologousCell DifferentiationColony-Forming Units AssayAntigens, CD34Transplantation, AutologousGraft vs Host DiseaseHematopoietic Stem Cell TransplantationCell LineageCells, CulturedMice, Inbred C57BLWhole-Body IrradiationHematopoiesisFlow CytometryAntineoplastic Combined Chemotherapy ProtocolsCell ProliferationBone and BonesStem Cell TransplantationLeukemiaTransplantation ConditioningAnemia, AplasticTransplantation ChimeraCyclophosphamideGraft SurvivalLiver TransplantationBone Marrow PurgingTissue DonorsCombined Modality TherapyBusulfanImmunohistochemistryHistocompatibility TestingTreatment OutcomeBone Marrow DiseasesHistocompatibilityTime FactorsLeukemia, Myeloid, AcuteTransplantation, IsogeneicGranulocyte Colony-Stimulating FactorStem Cell FactorLeukemia, Myelogenous, Chronic, BCR-ABL PositiveEmbryonic Stem CellsRadiation ChimeraRecurrenceKidney TransplantationHematopoietic Stem Cell MobilizationAdult Stem CellsHematologic NeoplasmsLeukemia, MyeloidPrecursor Cell Lymphoblastic Leukemia-LymphomaCell SeparationSurvival AnalysisLymphoma, Non-HodgkinImmunosuppressive AgentsBone Marrow ExaminationRemission InductionFetal BloodNeuronsGranulocytesT-LymphocytesMultipotent Stem CellsHepatic Veno-Occlusive DiseaseAntigens, CDGraft RejectionAcute DiseaseChemotherapy, AdjuvantBone RemodelingBone Marrow NeoplasmsLymphocyte DepletionStem Cell NicheChimeraMyelodysplastic SyndromesTransplantation ImmunologyEtoposideSurvival RateDisease-Free SurvivalMesenchymal Stem Cell TransplantationGraft vs Host ReactionImmunosuppressionHematologic DiseasesSevere Combined ImmunodeficiencyCarmustineMice, KnockoutCell DivisionMesenchymal Stromal CellsInterleukin-3Neural Stem CellsLeukocyte TransfusionPluripotent Stem CellsCytarabineHeart TransplantationMyeloid Progenitor CellsAntineoplastic AgentsHLA AntigensFollow-Up StudiesMice, Inbred BALB CStromal Cells